This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Winkle, R. A. Articles by Harrison, D. C. Search for Related Content PubMed PubMed Citation Articles by Winkle, R. A. Articles by Harrison, D. C.

Circulation, Vol 57, 787-792, Copyright © 1978 by American Heart Association

ARTICLES

The hemodynamic effects of intravenous tocainide in patients with heart disease

RA Winkle, JL Anderson, F Peters, PJ Meffin, RE Fowles and DC Harrison

In order to evaluate its hemodynamic actions, tocainide, a new orally effective antiarrhythmic drug, was given intravenously over a 15 minute period to 12 patients with compensated left ventricular dysfunction. Doses were 0.5 (4 patients) or 0.75 (8 patients) mg/kg/min. Hemodynamics and drug plasma concentrations were measured at the end and 15 minutes after the end of the infusion. Tocainide infusion produced small but statistically significant increases in the pulmonary and systemic vascular resistance, aortic and pulmonary arterial pressure, and left and right ventricular end-diastolic pressure. There was no significant change in left ventricular dp/dt, heart rate, or cardiac index. In patients with compensated left ventricular dysfunction, tocainide produces a small rise in vascular resistance and arterial pressure. Overall cardiac function is maintained with a small increase in left ventricular end-diastolic pressure.

This article has been cited by other articles:

				R. K. Mahapatra and D. Mahapatra Efficacy and Safety of Oral Tocainide in Refractory Ventricular Arrhythmia: A Preliminary Report on an Open Label Study Angiology, April 1, 1986; 37(4): 285 - 293. [Abstract] [PDF]